TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+3.1%/yr
Annual compound
5Y CAGR
+66.2%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
12.7x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $94.14M | -3.3% |
| 2024 | $97.38M | +5.4% |
| 2023 | $92.43M | +7.5% |
| 2022 | $85.98M | +1322.9% |
| 2021 | $6.04M | -18.7% |
| 2020 | $7.43M | +52.1% |
| 2019 | $4.89M | - |